Monday, August 04, 2025 8:13:05 AM
💥 🚀 BREAKING NEWS: “Under the AgFDA appropriations measure that the Senate also passed as part of the package on FRIDAY, THERE ARE NO LONGER PROVISIONS HEMP INDUSTRY stakeholders said would effectively eradicate the market by banning consumable hemp products with any “quantifiable” amount of THC.
“Meanwhile, Paul recently filed a standalone bill that would propose to triple the concentration of THC that the crop could legally contain”, while addressing multiple other concerns the Ind has expressed about federal regulations.”
https://www.researchgate.net/publication/393254483_Assessing_the_Impact_of_Cannabidiol_on_Seizure_Frequency_and_Severity_in_Animal_Models_of_Epilepsy
https://link.springer.com/article/10.1007/s11686-025-01090-3
“Meanwhile, Paul recently filed a standalone bill that would propose to triple the concentration of THC that the crop could legally contain”, while addressing multiple other concerns the Ind has expressed about federal regulations.”
https://www.researchgate.net/publication/393254483_Assessing_the_Impact_of_Cannabidiol_on_Seizure_Frequency_and_Severity_in_Animal_Models_of_Epilepsy
https://link.springer.com/article/10.1007/s11686-025-01090-3
Bullish
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
